Atlas Brown,Inc. Abbott Laboratories Transaction History

Atlas Brown,Inc.

$284 Million
Q3 2024

A detailed history of Atlas Brown,Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Atlas Brown,Inc. holds 20,740 shares of ABT stock, worth $2.46 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

20,740

Previous 20,534 1.0%

Holding current value

$2.46 Million

Previous $2.13 Million 10.83%

% of portfolio

0.83%

Previous 0.77%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$100.07 - $118.13 $20,614 - $24,334	206 Added 1.0%	20,740 $2.36 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $31,830 - $35,531	-316 Reduced 1.52%	20,534 $2.13 Million
Q1 2024 Apr 08, 2024	BUY	$109.52 - $120.96 $113,791 - $125,677	1,039 Added 5.24%	20,850 $2.37 Million
Q3 2023 Oct 17, 2023	BUY	$95.53 - $114.62 $95 - $114	1 Added 0.01%	19,811 $1.92 Million
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $1,410 - $1,572	14 Added 0.07%	19,810 $2.16 Million
Q1 2023 Apr 21, 2023	BUY	$96.86 - $114.01 $15,594 - $18,355	161 Added 0.82%	19,796 $2 Million
Q4 2022 Jan 05, 2023	SELL	$95.06 - $111.52 $210,938 - $247,462	-2,219 Reduced 10.15%	19,635 $0
Q3 2022 Oct 06, 2022	BUY	$96.76 - $112.03 $14,514 - $16,804	150 Added 0.69%	21,854 $2.12 Million
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.0%	21,704 $2.36 Million
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $808 - $990	-7 Reduced 0.03%	21,703 $3.05 Million
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $77,120 - $90,782	729 Added 3.47%	21,710 $2.52 Million
Q1 2021 Apr 13, 2021	SELL	$108.84 - $128.23 $27,101 - $31,929	-249 Reduced 1.17%	20,981 $2.51 Million
Q3 2020 Oct 15, 2020	BUY	$91.64 - $111.29 $91 - $111	1 Added 0.0%	21,230 $2.31 Million
Q2 2020 Jul 21, 2020	BUY	$76.57 - $98.0 $39,892 - $51,058	521 Added 2.52%	21,229 $1.94 Million
Q1 2020 Apr 16, 2020	BUY	$62.82 - $91.86 $3,141 - $4,593	50 Added 0.24%	20,708 $1.63 Million
Q4 2019 Jan 14, 2020	BUY	$78.51 - $87.4 $147,520 - $164,224	1,879 Added 10.01%	20,658 $1.79 Million
Q3 2019 Oct 29, 2019	SELL	$81.84 - $88.74 $157,869 - $171,179	-1,929 Reduced 9.32%	18,779 $1.57 Million
Q2 2019 Jul 24, 2019	SELL	$72.88 - $85.0 $15,960 - $18,615	-219 Reduced 1.05%	20,708 $1.74 Million
Q1 2019 Apr 12, 2019	SELL	$66.22 - $80.06 $86,086 - $104,078	-1,300 Reduced 5.85%	20,927 $1.67 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $264,600 - $299,753	-4,036 Reduced 15.37%	22,227 $1.61 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $60,749 - $73,286	-999 Reduced 3.66%	26,263 $1.93 Million
Q2 2018 Jul 11, 2018	SELL	$57.57 - $63.54 $1,151 - $1,270	-20 Reduced 0.07%	27,262 $1.71 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $82,491 - $93,266	1,466 Added 5.68%	27,282 $1.64 Million
Q4 2017 Jan 25, 2018	SELL	$53.68 - $57.47 $19,002 - $20,344	-354 Reduced 1.35%	25,816 $1.59 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $1.26 Million - $1.4 Million	26,170	26,170 $1.4 Million

Others Institutions Holding ABT

# of Institutions

3,167

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.19M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atlas Brown,Inc. with notifications on news.

Account